AmBase ABCP warns of going-concern as $109 cash, litigation costs drive losses

AmBase Corporation (OTCMKTS: ABCP) - Quick read: small holding company, no operating revenue, cash of $109 and heavy litigation-driven expenses and liabilities tied to its disputed 111 West 57th Street investment. Management warns of a going‑concern risk.

Key facts & figures (figures in thousands unless noted)
* Net loss - Three months ended June 30, 2025: $(1,083); Six months ended June 30, 2025: $(2,675).
* Net loss per share - Three months: $(0.01); Six months: $(0.03). Weighted average shares outstanding (basic): 84,938.
* Operating expenses (three months): Total $1,126 (2025) vs $2,005 (2024).
* Major expense lines (three months ended June 30, 2025 vs 2024): Compensation $322 vs $352; Professional & outside services $787 vs $1,570; Property operating $3 vs $6; Insurance $0 vs $12; Other operating $14 vs $65.
* Other income: $124 recorded in Q2 2025 (employee retention credit refund).
* Interest income/expense (three months): Interest income $0 vs $19 (prior year); Interest expense $(81) vs $51 (prior year).
* Balance sheet: Cash & cash equivalents $109; Total assets $109; Total liabilities $6,909; Total stockholders' equity (deficit) $(6,800); Accumulated deficit $(559,240).
* Related‑party debt: BARC Investments LLC loan $2,000 (rate 6.50%); R.A. Bianco loans $2,600 (aggregate at June 30, 2025).
* Accrued interest on related‑party loans: BARC $112; R.A. Bianco $79.
* Cash flow (six months): Net cash used by operations $(1,305); Net cash provided by financing $1,100; Cash at end of period $109 (vs $434 at June 30, 2024).
* Equity offering (completed April 1, 2024): 44,200,460 shares at $0.20 per share; proceeds $8,840.

What's happening inside the company - the essence
* AmBase is essentially a holding/ litigation company. It has no operating revenues and minimal assets (cash only). Management is focused on pursuing recoveries from the long‑running 111 West 57th Street litigation, which dominates strategy and cash needs.
* Management has reduced operating expense run‑rate in 2025 vs 2024 (professional/legal fees notably lower), which reduced the quarterly and year‑to‑date losses versus prior year periods. That is the main reason the net loss narrowed in 2025.
* Liquidity is tight: cash on hand $109 and accounts payable and accrued liabilities jumped to $2,309 (from $939 year‑end). The company depends on related‑party loans and possible litigation funding or equity/debt raises to stay afloat.
* The company's files disclose substantial doubt about going concern - management explicitly states current cash may not be sufficient to meet operating needs for the next 12 months without additional financing, reduced spending, or litigation recoveries.

Income statement - positives
* Operating expense control: Total operating expenses fell to $1,126 in Q2 2025 from $2,005 in Q2 2024 (professional and legal fees roughly halved).
* One‑time other income: $124 recognized in Q2 2025 (employee retention credit refund) offset losses.
* Net loss improvement: Q2 2025 net loss $(1,083) vs $(1,935) in Q2 2024; six‑month loss narrowed to $(2,675) from $(3,774).

Income statement - negatives / risks
* No operating revenue - the company records no sales; all results are expense‑driven and dependent on recoveries from litigation or asset realizations.
* Persistent net losses and large accumulated deficit: accumulated deficit $(559,240) - the company remains deeply in deficit on a GAAP basis.
* Interest expense and financing costs: interest expense increased in 2025 periods (reflecting related‑party loans and outstanding professional fee accruals).
* Results hinge on litigation outcomes and recoveries (111 West 57th) - these are uncertain, potentially costly, and could require more capital to pursue (the firm is exploring litigation funders who would take multiples of any recovery).
* Working capital squeeze: cash burn continues, accounts payable increased - without new capital or favorable litigation results the company may not be able to fund operations.

Key operational & governance notes
* Single operating segment; management actively pursuing legal strategies and potential litigation funding (including related‑party lender conversions to litigation funding agreements).
* Related‑party financing is material (BARC and the CEO, R.A. Bianco) - that financing is both a lifeline and a governance point to watch.
* The company took a full impairment on its 111 West 57th equity investment in 2017 (material to historical equity). Ongoing complex litigation has many pending motions and appeals - outcomes will determine any material recovery potential.

Bottom line / investor takeaway
* AmBase (OTCMKTS: ABCP) is a litigation‑centric holding company with very limited cash, continued quarterly losses and a large accumulated deficit. The company has reduced spend and narrowed losses in 2025, and it recorded a $124 one‑time income item, but liquidity remains precarious. The business case rests on successful litigation outcomes, additional funding (equity, debt or third‑party litigation funding), or further cost cuts. Expect volatility and high execution risk until material recoveries or stable financing are secured.

If you want, I can draft a one‑page checklist of triggers/filings to watch next (court rulings, financing events, debt conversions, cash balance updates and material pre‑trial rulings) to monitor progress.